2 CTCCAS# 42074-68-0 |
- (24R)-MC 976
Catalog No.:BCC1289
CAS No.:112828-09-8
- (24S)-MC 976
Catalog No.:BCC1291
CAS No.:112849-14-6
- 1alpha, 25-Dihydroxy VD2-D6
Catalog No.:BCC1299
CAS No.:216244-04-1
- 1alpha, 24, 25-Trihydroxy VD2
Catalog No.:BCC1298
CAS No.:457048-34-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 42074-68-0 | SDF | Download SDF |
PubChem ID | 94524 | Appearance | Powder |
Formula | C19H14Cl2 | M.Wt | 313.23 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-chloro-2-[chloro(diphenyl)methyl]benzene | ||
SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)Cl | ||
Standard InChIKey | JFLSOKIMYBSASW-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H14Cl2/c20-18-14-8-7-13-17(18)19(21,15-9-3-1-4-10-15)16-11-5-2-6-12-16/h1-14H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2 CTC Dilution Calculator
2 CTC Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1925 mL | 15.9627 mL | 31.9254 mL | 63.8508 mL | 79.8136 mL |
5 mM | 0.6385 mL | 3.1925 mL | 6.3851 mL | 12.7702 mL | 15.9627 mL |
10 mM | 0.3193 mL | 1.5963 mL | 3.1925 mL | 6.3851 mL | 7.9814 mL |
50 mM | 0.0639 mL | 0.3193 mL | 0.6385 mL | 1.277 mL | 1.5963 mL |
100 mM | 0.0319 mL | 0.1596 mL | 0.3193 mL | 0.6385 mL | 0.7981 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
2 CTC
- d[Leu4,Lys8]-VP
Catalog No.:BCC5981
CAS No.:42061-33-6
- Atractylenolide III acetate
Catalog No.:BCC9147
CAS No.:
- Mezlocillin Sodium
Catalog No.:BCC4678
CAS No.:42057-22-7
- Clonidine HCl
Catalog No.:BCC4325
CAS No.:4205-91-8
- Estriol 17-sulfate
Catalog No.:BCN2237
CAS No.:42028-21-7
- Fenofibric acid
Catalog No.:BCC8982
CAS No.:42017-89-0
- Antitumor Compound 1
Catalog No.:BCC5397
CAS No.:420126-30-3
- Dihydropashanone
Catalog No.:BCN4635
CAS No.:41997-41-5
- 5-Chloro-1,10-phenanthroline
Catalog No.:BCC3713
CAS No.:4199-89-7
- (S)-(-)-Propranolol hydrochloride
Catalog No.:BCC6809
CAS No.:4199-10-4
- Glabranin
Catalog No.:BCN5480
CAS No.:41983-91-9
- Pinocembrin chalcone
Catalog No.:BCN7223
CAS No.:4197-97-1
- Lucialdehyde A
Catalog No.:BCN2449
CAS No.:420781-84-6
- AK-7
Catalog No.:BCC5426
CAS No.:420831-40-9
- H2L 5765834
Catalog No.:BCC6311
CAS No.:420841-84-5
- Tetradehydropodophyllotoxin
Catalog No.:BCN8395
CAS No.:42123-27-3
- N,N-Bis(2-chloroethyl)-p-toluenesulphonamide
Catalog No.:BCC9060
CAS No.:42137-88-2
- Artemyriantholide D
Catalog No.:BCN7478
CAS No.:421558-76-1
- Cephalocyclidin A
Catalog No.:BCN5481
CAS No.:421583-14-4
- DOI hydrochloride
Catalog No.:BCC5925
CAS No.:42203-78-1
- Triacetyl Resveratrol
Catalog No.:BCC6482
CAS No.:42206-94-0
- Hesperadin
Catalog No.:BCC2174
CAS No.:422513-13-1
- N-(4-Cyanophenyl)glycine
Catalog No.:BCC9057
CAS No.:42288-26-6
- PYZD-4409
Catalog No.:BCC4253
CAS No.:423148-78-1
5-Cyano-2,3-ditolyl tetrazolium chloride (CTC) reduction in a mesophilic anaerobic digester: measuring redox behavior, differentiating abiotic reduction, and comparing FISH response as an activity indicator.[Pubmed:12401227]
J Microbiol Methods. 2003 Jan;52(1):59-68.
The tetrazolium salt 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) has been widely applied to assess microbiological activity in environmental samples. CTC reduction has previously been quantified in a variety of anaerobic systems (i.e., fermentative, nitrate reducing, sulfate reducing) using direct microscopy, solvent extraction, and flow cytometry. In this work, extracellular CTC reduction was observed and distinguished from its intercellular counterparts by the amorphous character and near uniform fluorescence of the resulting formazan precipitates (CTF). Fluorescence yielded by non-cellular-associated formazan precipitates bleached much more rapidly than CTF formed within cells under identical UV exposure (<2 min). Dehydrogenase activity assays and fluorescent in situ hybridization (FISH) were simultaneously carried out in microcosms containing active anaerobic digester biomass, propylene glycol, and settled sewage centrate for direct comparison. In substrate limited microcosms, quantitative FISH measurements remained well above their detection limit indicating sustained intercellular ribosomal RNA concentrations over a 5-day period, while dehydrogenase assays (CTC) decreased to background levels within 14 h of substrate limitation. Results from this work suggest that CTC reduction in cell-free samples may impede accurate enzyme activity measurements, particularly when quantification involves solvent extraction, flow cytometry, or software-aided counting. In addition, activity assessment in anaerobic digesters using FISH and CTC reduction assays may be comparable until substrate becomes limited.
New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs.[Pubmed:20198227]
Chem Commun (Camb). 2010 Mar 21;46(11):1842-4.
Reduction of anticancer prodrugs such as ctc-[PtCl(2)(CH(3)CO(2))(2)(NH(3))(Am)] can yield three products in addition to the expected cis-[PtCl(2)(NH(3))(Am)]. A possible explanation is that reduction proceeds by several pathways where in addition to the loss of two axial ligands, one axial (acetato) and one equatorial (chlorido) ligand, or two equatorial ligands are eliminated.
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0.[Pubmed:15361909]
Bone Marrow Transplant. 2004 Nov;34(9):787-94.
Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST. We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were significantly associated with the outcome confirming the predictive value of both the systems. A total of 15 patients died of disease progression, and 12 of transplant-related mortality: RRT (n = 2), graft-versus-host disease (GVHD) (n = 7), infection (n = 1), and others (n = 2). GVHD-related deaths primarily resulted from infections after steroid treatment (n = 6) and bronchiolitis obliterans (n = 1). This study shows that NCI-CTC is appropriate in toxicity evaluation of RIST, and that its application to RIST enables a toxicity comparison between RIST and other types of cancer treatments. Since GVHD is a significant problem in RIST, modifications are required to evaluate immunological complications following RIST.